Telix Pharmaceuticals Limited Stock Analysis
TLX Stock | 14.70 0.07 0.47% |
Telix Pharmaceuticals Limited is undervalued with Real Value of 18.26 and Target Price of 32.5. The main objective of Telix Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Telix Pharmaceuticals Limited is worth, separate from its market price. There are two main types of Telix Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Telix Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Telix Pharmaceuticals is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Telix Stock trading window is adjusted to America/New York timezone.
Telix |
Telix Stock Analysis Notes
The company had not issued any dividends in recent years. Telix Pharmaceuticals had 1:1000 split on the 29th of October 2013. To find out more about Telix Pharmaceuticals Limited contact the company at 61 3 9093 3855 or learn more at https://telixpharma.com.Telix Pharmaceuticals Quarterly Total Revenue |
|
Telix Pharmaceuticals Investment Alerts
Telix Pharmaceuticals generated a negative expected return over the last 90 days | |
Latest headline from finance.yahoo.com: 3 Stocks Estimated To Be Trading At A Discount Of Up To 32.9 |
Telix Pharmaceuticals Environmental, Social, and Governance (ESG) Scores
Telix Pharmaceuticals' ESG score is a quantitative measure that evaluates Telix Pharmaceuticals' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Telix Pharmaceuticals' operations that may have significant financial implications and affect Telix Pharmaceuticals' stock price as well as guide investors towards more socially responsible investments.
Telix Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 4.92 B.Telix Profitablity
The company has Net Profit Margin of 0.08 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.09 %, which entails that for every 100 dollars of revenue, it generated $0.09 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.02 | 0.02 | |
Return On Capital Employed | 0.07 | 0.07 | |
Return On Assets | 0.01 | 0.01 | |
Return On Equity | 0.03 | 0.04 |
Management Efficiency
Telix Pharmaceuticals has Return on Asset of 0.0797 % which means that on every $100 spent on assets, it made $0.0797 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2049 %, implying that it generated $0.2049 on every 100 dollars invested. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.02 in 2024. Return On Capital Employed is likely to rise to 0.07 in 2024. At this time, Telix Pharmaceuticals' Other Current Assets are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.02 in 2024, whereas Total Assets are likely to drop slightly above 253.4 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.15) | (0.18) | |
Tangible Book Value Per Share | (0.25) | (0.26) | |
Enterprise Value Over EBITDA | (4.61) | (4.84) | |
Price Book Value Ratio | (4.22) | (4.43) | |
Enterprise Value Multiple | (4.61) | (4.84) | |
Price Fair Value | (4.22) | (4.43) | |
Enterprise Value | 8.1 M | 7.7 M |
The decision-making processes within Telix Pharmaceuticals are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin 0.0949 | Profit Margin 0.0762 | Beta 2.384 | Return On Assets 0.0797 | Return On Equity 0.2049 |
Technical Drivers
As of the 25th of November, Telix Pharmaceuticals has the Coefficient Of Variation of (429.93), risk adjusted performance of (0.17), and Variance of 2.47. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telix Pharmaceuticals, as well as the relationship between them.Telix Pharmaceuticals Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Telix Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Telix Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Telix Pharmaceuticals Predictive Daily Indicators
Telix Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Telix Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Telix Pharmaceuticals Forecast Models
Telix Pharmaceuticals' time-series forecasting models are one of many Telix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Telix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Telix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telix Pharmaceuticals. By using and applying Telix Stock analysis, traders can create a robust methodology for identifying Telix entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.01 | 0.01 | |
Operating Profit Margin | 0.03 | 0.04 | |
Net Profit Margin | 0.01 | 0.01 | |
Gross Profit Margin | 0.62 | 0.65 |
Current Telix Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Telix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Telix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
32.5 | Strong Buy | 1 | Odds |
Most Telix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Telix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Telix Pharmaceuticals, talking to its executives and customers, or listening to Telix conference calls.
Telix Stock Analysis Indicators
Telix Pharmaceuticals Limited stock analysis indicators help investors evaluate how Telix Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Telix Pharmaceuticals shares will generate the highest return on investment. By understating and applying Telix Pharmaceuticals stock analysis, traders can identify Telix Pharmaceuticals position entry and exit signals to maximize returns.
Begin Period Cash Flow | 116.3 M | |
Total Stockholder Equity | 148.9 M | |
Property Plant And Equipment Net | 30.5 M | |
Cash And Short Term Investments | 123.2 M | |
Shares Float | 282.3 M | |
Cash | 123.2 M | |
200 Day M A | 14.9499 | |
50 Day M A | 14.9499 | |
Total Current Liabilities | 157.4 M | |
Forward Price Earnings | 69.9301 | |
Interest Expense | 13.1 M | |
Free Cash Flow | -10.8 M | |
Operating Income | 17 M | |
Other Current Assets | 19.5 M | |
Accounts Payable | 32.8 M | |
Net Debt | -105.8 M | |
Accumulated Other Comprehensive Income | -33.7 M | |
Other Operating Expenses | 496.7 M | |
Non Current Assets Total | 173.5 M | |
Total Current Assets | 224.8 M | |
Liabilities And Stockholders Equity | 398.3 M | |
Non Currrent Assets Other | 586 K |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.